Skip to main content

Scientific Expertise

World Vaccine Congress September

Sept 28 - Oct 1


qPCR/sequencing assay development to support vaccine clinical studies and trials

Presented by Mark Wissel

Optimizing Flow Cytometry Quantitation of Rare-Cell Populations and Its Application In Immunotherapy

Jul 29

Eurofins Viracor invites you to add the upcoming event to your calendar. This informative webinar, featuring our flow cytometry expert, Dr. Brian Maybruck, will focus on the use of Flow Cytometry for rare cell quantitation, and its application in drug development.

Multiparameter flow cytometry applications and future outlook

Flow cytometry is a very powerful and reliable alternative to many other methods used for clinical drug development. Consider that it can simultaneously measure multiple parameters on tens of thousands of cells, with a resolution down to a single cell level, robustly and rapidly (greater than 1000 samples per day).

Eurofins BioPharma News (July 2020)

Check out the latest BioPharma Services newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Eurofins BioPharma News (February 2020)

Check out the latest BioPharma Services newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

World Vaccine and Immunotherapy Conference 2019

Dec 3

Watch Dr. Steve Kleiboeker’s presentation from the 3rd World Vaccine and Immunotherapy Congress in San Francisco, CA

Bioanalysis ZONE Podcast

Click here to check out the Bioanalysis ZONE podcast on T-cell immunity monitoring and assay development, featuring Steven Kleiboeker, PhD, our VP of Research & Development at Viracor Eurofins BioPharma Services.

Eurofins BioPharma News (October 2019)

Check out the latest BioPharma Services newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Immunogenicity Assay Development, Validation & Transfer in a Vaccine Candidate Clinical Trial

A large global pharmaceutical company, with a promising new vaccine candidate, partnered with Viracor Eurofins to perform immunogenicity testing as part of their clinical trial development. Several specific areas of expertise were called upon to enable the Viracor team to deliver multiple precise, robust and sensitive assays to meet the sponsor's needs.

Clinical Development Testing Services Info Sheet for Cell & Gene Therapy

Immunotherapies have emerged as some of the most promising approaches to treating cancer patients. Download the Info Sheet to see what assay development and testing services Viracor Eurofins offers for supporting clinical development of Cell & Gene therapy candidates.

Back to top